Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses

Biomaterials

Volumn 33, Issue 25, 2012, Pages 5935-5946

  Bioley, Gilles ^a   Lassus, Anne ^b   Bussat, Philippe ^b   Terrettaz, Jacques ^b   Tranquart, François ^b   Corthésy, Blaise ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Antibodies; Antigen delivery; Dendritic cells; Gas filled microbubbles; Microparticles; T cell immunity

Indexed keywords

ANTIGEN DELIVERY; DENDRITIC CELLS; MICRO-PARTICLES; MICROBUBBLES; T CELLS;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; CELLS; CYTOLOGY; RECOMBINANT PROTEINS; SILVER;

ANTIBODIES;

ALBUMIN ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FEMALE; GAS FILLED MICROBUBBLE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MICROBUBBLE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENCE; GASES; HUMANS; HYBRIDOMAS; IMMUNITY; INJECTIONS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICROBUBBLES; OVALBUMIN; PEPTIDES; PHAGOCYTOSIS;

MUS;

EID: 84862198231     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.004     Document Type: Article

References (58)

1. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004, 3(6):527-532.
2. Wilson S.R., Burns P.N. Microbubble-enhanced US in body imaging: what role?. Radiology 2010, 257(1):24-39.
3. Gessner R., Dayton P.A. Advances in molecular imaging with ultrasound. Mol Imaging 2010, 9(3):117-127.
4. Suzuki R., Oda Y., Utoguchi N., Namai E., Taira Y., Okada N., et al. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 2009, 133(3):198-205.
5. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010, 31(30):7813-7826.
6. Geers B., Lentacker I., Alonso A., Sanders N.N., Demeester J., Meairs S., et al. Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm 2011, 8(6):2244-2251.
7. Lemmon J.C., McFarland R.J., Rybicka J.M., Balce D.R., McKeown K.R., Krohn R.M., et al. In vitro and in vivo transfection of primary phagocytes via microbubble-mediated intraphagosomal sonoporation. J Immunol Methods 2011, 371(1-2):152-158.
8. Ashokkumar M. The characterization of acoustic cavitation bubbles - an overview. Ultrason Sonochem 2011, 18(4):864-872.
9. Zhou Y., Yang K., Cui J., Ye J.Y., Deng C.X. Controlled permeation of cell membrane by single bubble acoustic cavitation. J Control Release 2012, 157(1):103-111.
10. Bioley G., Bussat P., Lassus A., Schneider M., Terrettaz J., Corthesy B. The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells. Biomaterials 2012, 33(1):333-342.
11. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
12. Trombetta E.S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005, 23:975-1028.
13. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002, 20:621-667.
14. Swartz M.A., Hubbell J.A., Reddy S.T. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol 2008, 20(2):147-156.
15. Shklovskaya E. Fazekas de St Groth B. Balancing tolerance and immunity: the role of dendritic cell and T cell subsets. Methods Mol Biol 2007, 380:25-46.
16. Tuettenberg A., Becker C., Correll A., Steinbrink K., Jonuleit H. Immune regulation by dendritic cells and T cells-basic science, diagnostic, and clinical application. Clin Lab 2011, 57(1-2):1-12.
17. Wilson-Welder J.H., Torres M.P., Kipper M.J., Mallapragada S.K., Wannemuehler M.J., Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 2009, 98(4):1278-1316.
18. van Duin D., Medzhitov R., Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol 2006, 27(1):49-55.
19. Idoyaga J., Lubkin A., Fiorese C., Lahoud M.H., Caminschi I., Huang Y., et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci USA 2011, 108(6):2384-2389.
20. Sancho D., Mourao-Sa D., Joffre O.P., Schulz O., Rogers N.C., Pennington D.J., et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008, 118(6):2098-2110.
21. Gamvrellis A., Leong D., Hanley J.C., Xiang S.D., Mottram P., Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004, 82(5):506-516.
22. Lambrecht B.N., Kool M., Willart M.A., Hammad H. Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 2009, 21(1):23-29.
23. Rice-Ficht A.C., Arenas-Gamboa A.M., Kahl-McDonagh M.M., Ficht T.A. Polymeric particles in vaccine delivery. Curr Opin Microbiol 2010, 13(1):106-112.
24. Henriksen-Lacey M., Korsholm K.S., Andersen P., Perrie Y., Christensen D. Liposomal vaccine delivery systems. Expert Opin Drug Deliv 2011, 8(4):505-519.
25. Bachmann M.F., Jennings G.T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10(11):787-796.
26. Oyewumi M.O., Kumar A., Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 2010, 9(9):1095-1107.
27. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009, 10(12):1237-1244.
28. Vieira O.V., Botelho R.J., Grinstein S. Phagosome maturation: aging gracefully. Biochem J 2002, 366(3):689-704.
29. Reddy S.T., Swartz M.A., Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 2006, 27(12):573-579.
30. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997, 158(6):2723-2730.
31. Tinkov S., Bekeredjian R., Winter G., Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009, 98(6):1935-1961.
32. Miller D.L., Averkiou M.A., Brayman A.A., Everbach E.C., Holland C.K., Wible J.H., et al. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 2008, 27(4):611-663.
33. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422(6927):37-44.
34. Burgdorf S., Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 2008, 20(1):89-95.
35. Villadangos J.A., Ploegh H.L. Proteolysis in MHC class II antigen presentation: who's in charge?. Immunity 2000, 12(3):233-239.
36. Rodriguez A., Regnault A., Kleijmeer M., Ricciardi-Castagnoli P., Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999, 1(6):362-368.
37. Burgdorf S., Kautz A., Bohnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316(5824):612-616.
38. Norbury C.C., Basta S., Donohue K.B., Tscharke D.C., Princiotta M.F., Berglund P., et al. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 2004, 304(5675):1318-1321.
39. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci USA 2003, 100(22):12889-12894.
40. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003, 425(6956):397-402.
41. Tanaka Y., Taneichi M., Kasai M., Kakiuchi T., Uchida T. Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells. PLoS One 2010, 5(12):e15225.
42. Taneichi M., Ishida H., Kajino K., Ogasawara K., Tanaka Y., Kasai M., et al. Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. J Immunol 2006, 177(4):2324-2330.
43. Harding C.V., Collins D.S., Kanagawa O., Unanue E.R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J Immunol 1991, 147(9):2860-2863.
44. Gras-Masse H. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations. Mol Immunol 2001, 38(6):423-431.
45. Badiee A., Jaafari M.R., Khamesipour A., Samiei A., Soroush D., Kheiri M.T., et al. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition. Colloids Surf B Biointerfaces 2009, 74(1):37-44.
46. Garnier F., Forquet F., Bertolino P., Gerlier D. Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition. Vaccine 1991, 9(5):340-345.
47. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007, 7(7):543-555.
48. Henri S., Poulin L.F., Tamoutounour S., Ardouin L., Guilliams M., de Bovis B., et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010, 207(1):189-206.
49. Igyarto B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35(2):260-272.
50. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38(5):1404-1413.
51. Allan R.S., Waithman J., Bedoui S., Jones C.M., Villadangos J.A., Zhan Y., et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006, 25(1):153-162.
52. Calabro S., Tortoli M., Baudner B.C., Pacitto A., Cortese M., O'Hagan D.T., et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 2011, 29(9):1812-1823.
53. Ng G., Sharma K., Ward S.M., Desrosiers M.D., Stephens L.A., Schoel W.M., et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008, 29(5):807-818.
54. Renaudet O., Dasgupta G., Bettahi I., Shi A., Nesburn A.B., Dumy P., et al. Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity. PLoS One 2010, 5(6):e11216.
55. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006, 212:28-50.
56. Freitas do Rosario A.P., Lamb T., Spence P., Stephens R., Lang A., Roers A., et al. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from Severe Immunopathology during Malaria Infection. J Immunol 2012, 188(3):1178-1190.
57. Kadowaki N. The divergence and interplay between pDC and mDC in humans. Front Biosci 2009, 14:808-817.
58. Sever A.R., Mills P., Jones S.E., Mali W., Jones P.A. Sentinel node identification using microbubbles and contrast-enhanced ultrasonography. Clin Radiol 2012.